Healthcare Services

Biomarker Testing Market: Key Trends and Expansion Potential

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Biomarker Testing Market From 2026 To 2030?

The size of the biomarker testing market has experienced rapid expansion in recent years. This market is projected to increase from $19.75 billion in 2025 to $22.26 billion in 2026, registering a compound annual growth rate (CAGR) of 12.7%. The growth observed during the historic period was primarily driven by the increasing prevalence of chronic diseases, the expansion of clinical research activities, the rising adoption of molecular diagnostics, a growing demand for targeted therapies, and the availability of advanced testing platforms.

The biomarker testing market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $35.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.4%. This growth in the forecast period is primarily driven by increasing investments in personalized medicine, the rising application of biomarkers in drug development, the expansion of oncology and infectious disease testing, the growing demand for minimally invasive diagnostics, and advancements in multi-omics technologies. Furthermore, major trends for this period include the increasing adoption of precision medicine diagnostics, the rising use of companion diagnostics, the growing integration of AI in biomarker analysis, the expansion of liquid biopsy testing, and an enhanced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

What Major Factors Are Driving The Biomarker Testing Market Forward?

The escalating incidence of cancer is projected to fuel the expansion of the biomarker testing market in the future. Cancer refers to a collection of diseases characterized by the uncontrolled proliferation and dissemination of abnormal cells within the body. This growing cancer burden is attributed to lifestyle choices such as an unhealthy diet, smoking, insufficient physical activity, and excessive alcohol consumption. Biomarker testing enhances cancer detection by enabling early and precise identification of disease-specific markers, thus improving diagnostic accuracy. Additionally, it supports personalized treatment strategies, leading to better patient outcomes and more effective healthcare management. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, approximately 165,000 new cancer cases were diagnosed in 2023, with projections indicating that around 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Consequently, the increasing prevalence of cancer is driving the growth of the biomarker testing market.

What Segment Categories Shape The Biomarker Testing Market Segment Landscape?

The biomarker testing market covered in this report is segmented –

1) By Product Type: Consumables, Instruments, Services

2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, Immunoassays, Other Technologies

3) By Application: Oncology, Cardiology, Neurology, Infectious Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Consumables: Reagents, Assay Kits, Sample Collection Devices, Chemicals And Buffers

2) By Instruments: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Microarray Systems, Mass Spectrometry Instruments, Immunoassay Analyzers

3) By Services: Biomarker Discovery Services, Diagnostic Testing Services, Companion Diagnostic Development, Clinical Trial Testing Services, Contract Research Organization (CRO) Services

Which Trends Are Impacting The Progress Of The Biomarker Testing Market?

Leading firms within the biomarker testing market are concentrating their efforts on creating sophisticated technological solutions, including immunohistochemistry (IHC) technology, with the aim of boosting diagnostic precision, facilitating prompt disease identification, and aiding individualized treatment approaches. This immunohistochemistry (IHC) technology represents a laboratory method employing antibodies to locate particular proteins in tissue specimens, thereby assisting in the identification and visualization of biomarkers crucial for disease diagnosis and investigative purposes. As an example, in July 2023, Quest Diagnostics Incorporated, a medical laboratories firm situated in the US, introduced a novel tissue-based prostate cancer biomarker test via its AmeriPath division, designed to improve diagnostic exactness utilizing its unique biomarkers EV1, EV2, and EV3. The introduction of this test fulfills a vital clinical requirement by assisting medical professionals in more accurately identifying and distinguishing aggressive prostate cancer types, enhancing the uniformity of grading, and directing suitable treatment plans for individuals.

Who Are The Companies Operating Across The Biomarker Testing Market Value Chain?

Major companies operating in the biomarker testing market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Hologic Inc., Charles River Laboratories International Inc., PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Myriad Genetics Inc., Guardant Health Inc., Sino Biological Inc., Proteome Sciences plc

Get The Full Biomarker Testing Market Report:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Which Region Leads The Biomarker Testing Market In Overall Market Size?

North America was the largest region in the biomarker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Biomarker Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/biomarker-testing-global-market-report

Browse Through More Reports Similar to the Global Biomarker Testing Market 2026, By The Business Research Company

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Clinical Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarker Discovery Outsourcing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795